MEI Pharma Inc Cash Flow Reinvestment Rate

Latest as of December 2020: 1.27x

MEI Pharma Inc cash flow reinvestment rate. MEI Pharma Inc (MEIP) has a Cash Flow Reinvestment Rate of 1.27x as of December 2020, reinvesting $5.14 Million (capex $56.00K plus investments $-5.09 Million) from operating cash flow of $4.05 Million. Explore MEI Pharma Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

1.27x
(Capex + Investments) / Operating CF

Total Reinvested

$5.14 Million
Capex + Investments

Operating Cash Flow

$4.05 Million
USD

Capital Expenditures

$56.00K
USD

Cash Flow Reinvestment Rate of MEI Pharma Inc (2017–2020)

Cash flow reinvestment rate of MEI Pharma Inc from 2017 to 2020. Historical reinvestment intensity for MEI Pharma Inc across 2 annual periods. Explore MEIP capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

MEI Pharma Inc Cash Flow Reinvestment Rate by Year (2017–2020)

MEI Pharma Inc cash flow reinvestment rate by year from 2017 to 2020. Year-by-year capital reinvestment analysis for MEI Pharma Inc. For the full cash flow conversion analysis, see MEIP cash flow conversion.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2020 3.10x $106.29 Million $34.26 Million $894.00K ▲ +7.3%
2017 2.89x $10.08 Million $3.49 Million $51.00K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow